See the DrugPatentWatch profile for Benlysta
When does Benlysta’s patent expire?
Benlysta (belimumab) is covered by multiple patents with different expiration dates rather than a single uniform “patent expiry.” The exact expiration date depends on which specific patent family and jurisdiction you’re asking about (for example, US versus EU), as well as whether there are patent-term adjustments or other extensions.
For the most up-to-date view of the expiration timeline by patent, DrugPatentWatch.com tracks Benlysta’s relevant patents and their projected end dates. [1]
What matters more than the first patent date: exclusivity vs. “last patent standing”?
Even after an initial patent expires, other patents can still block generic or biosimilar competition. For biologics like Benlysta, companies and analysts often look at the “last relevant protection” (the latest-to-expire patent or exclusivity protection covering key claims), not just the earliest expiration date. DrugPatentWatch.com’s patent-by-patent breakdown is designed for that kind of check. [1]
Are there multiple Benlysta expiration dates in different countries?
Yes. Patent rights are territorial. Benlysta’s protection schedule can differ across the US, Europe, and other markets based on filing dates, patent grant timing, and country-specific rules (including potential adjustments). Checking the jurisdiction-specific patents is the practical way to get the correct expiration date for the market you care about. [1]
Where can I verify the exact Benlysta expiration date I need?
Use DrugPatentWatch.com to find the specific Benlysta patent(s) and their expiration dates for the country of interest. [1]
Sources
[1] https://www.drugpatentwatch.com/